Sign Up | Log In | What is SocialPicks?

The Malaysia Fund Inc. (MF) Trade Now » Rate MF - Discuss MF - Add to Watch List

Sector: Financial > Industry: Misc. Financial Services

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

70.0%

Top:

83.0%

Rate MF:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

MF: Bull or Bear?

From: SocialPicks | Blogsphere | All

SocialPicks Community

BUY: The Malaysia Fund (Public, NYSE: MF) MF

14%

-11.65%
in 979 days

BUY: The Malaysia Fund (Public, NYSE: MF) $7.60 (3/1/07) Sell price: $7.98 or Sell date: April 1, 2007Stop loss: $7.25 (-4.6%) Oversold on Asian market lowsSelling deeply discounted to NAVImproved valuation after today’s strong rebound of nearly 2%See previous post Profile: The Malaysia Fund, Inc. operates as a diversified, [...]

Continue reading »

By fivepercentstocks (-18.03% risk: aggressive) 03/07/07

Comment

From the Blogosphere

Rights Given to MF holders By SEBI :)

17%

http://smcinvestment.wordpress.com/2009/09/16/rights-made-available-to-mf-holders-by-sebi/

The recent move by SEBI, banning entry load and capping exit load, among other things, has turned the spotlight on the possible improvement in rights of mutual fund (MF) holders in the country.

Continue reading »

By tushar makhija (-3.92% risk: aggressive) 09/16/09

Comment

Know About the Rights Available to MF Holders :)

17%

http://smcinvestment.wordpress.com/2009/09/16/know-about-the-rights-available-to-mf-holders/

The recent move by SEBI, banning entry load and capping exit load, among other things, has turned the spotlight on the possible improvement in rights of mutual fund (MF) holders in the country.

Continue reading »

By tushar makhija (-3.92% risk: aggressive) 09/16/09

Comment

Incyte Presents Investors with Unique Dilemmas

A drug with an almost certain approval and immediate sales potential of hundreds of millions of dollars is an asset very few biotech companies possess. In that sense, Incyte (INCY), which is developing a breakthrough drug for blood disorders, represents a unique opportunity in an industry plagued by risk and uncertainty. Incyte is also unique in its problematic capital structure, which makes an otherwise simple investment decision a tricky one.

<>Incyte’s lead drug is INCB18424 (aka 424), currently in two registration trials in myelofibrosis (MF). Myelofibrosis is a blood disorder in which ...

Continue reading »

By trackseekingalpha (-13.69% risk: aggressive) 08/10/09

Comment

Trading Radar for 5/21: Gap (GPS), salesforce.com (CRM), GameStop (GME), Suntech (STP), LDK Solar (LDK), Autodesk (ADSK), Buckle (BKE), Excel Maritime (EXM) Report; Initial Claims Due

The Trading Radar highlights key earnings and economic announcements for tomorrow's trading session:Before Market Opens:Economics:8:30 am ET

Initial Jobless Claims for 5/16

Earnings:Barnes and Noble (NYSE: BKS) - consensus loss $0.15GameStop (NYSE: GME) - consensus EPS $0.42MF Global (NYSE: MF) - consensus EPS $0.08New York & Company (NYSE: NWY) - consensus loss $0.08Suntech (NYSE: STP) - consensus loss $0.06Toro (NYSE: TTC) - consensus EPS $0.91Intraday or Not Specified:Economics:10am ET<>

Leading Indicators for April - Street expects 0.6%

<> Philly Fed Index for May - Street e...

Continue reading »

By Street Insider (+14.43% risk: moderate) 05/20/09

Comment

Trading Radar for 5/21: Gap (GPS), salesforce.com (CRM), GameStop (GME), Suntech (STP), LDK Solar (LDK), Autodesk (ADSK), Buckle (BKE), Excel Maritime (EXM) Report; Initial Claims Due

The Trading Radar highlights key earnings and economic announcements for tomorrow's trading session:Before Market Opens:Economics:8:30 am ET

Initial Jobless Claims for 5/16

Leading Indicators for April - Street expects 0.6%

<> Philly Fed Index for May - Street e...

Continue reading »

By Street Insider (+14.43% risk: moderate) 05/20/09

Comment

« previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
next »

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.57%	370
2	Gerald Greene	18.14	+68.57%	207
3	stockmarketfunding.com	17.66	+25.68%	53
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+77.15%	34

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
XOM	Exxon Mobil Corp
GE	General Electric Company
FNM	Fannie Mae
F	Ford Motor Company
POT	Potash Corp. of Saskatchewan Inc.
KO	The CocaCola Company

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

CHLN		CHLN up 20% China housing and land development by legan
CROX		Crocs' turnaround story is still intact by cocacolabuffet
TTWO		Take Two on Take Two Interactive by jgarner3999
F		take the money and run by benkschroeder
NPD		NPD - CHINA NEPSTAR POISED FOR SIGNIFICANT GROWTH by penny7

... more »

StreetInsider.com on MF

Visit streetinsider.com

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About The Malaysia Fund Inc. - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.